Avanos Medical, Inc. AVNS
Set alert
At close · Jul 24
After hours · Jul 24, 4:03 PM ET
- YTD
- +122.53%
- 1 year
- +105.34%
- Open
- 24.98
- Prev close
- 24.99
- Mkt cap
- 1.17B
- Vol
- 432.16K
- Avg vol
- 700.36K
- EPS
- -1.61
- P/E
- -16.65
- Div yield
- 0.00%
More statistics
- Low
- 24.98
- High
- 25.00
- Beta
- 1.57
- Inst. own
- 93.15%
- Dividend
- 0.00
- Earnings
- Aug 10, 2026
6M chart
Events in this range
- Feb 24, 2026Earnings: 0.29; estimate 0.24; surprise 20.83%
- May 5, 2026Earnings: 0.22; estimate 0.16; surprise 37.5%
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | May 1, 2026 | 6 months ago |
| RSI: Overbought | Apr 14, 2026 | 6 months ago |
| SMA: Bullish | Apr 9, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 31, 2026 | 7 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 26, 2026 | 7 months ago |
| SMA: Bearish | Mar 18, 2026 | 7 months ago |
| SMA: Bullish | Mar 11, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 24, 2026 | 8 months ago |
| RSI: Overbought | Feb 4, 2026 | 9 months ago |
Key statistics
- Market cap
- 1.17B
- Enterprise value
- 1.24B
- Trailing P/E
- -16.65
- PEG ratio
- -0.39
- Price / sales
- 1.64
- Price / book
- 1.48
- Beta
- 1.57
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -9.69%
- Total cash
- 0
- Total debt
- 3
- Return on equity
- -8.91%
Analyst view
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 10, 2026
Expected Aug 10, 2026. Consensus EPS estimate 0.16.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 10, 2026 | Jun 30, 2026 | 0.16 | — | — | — |
| May 5, 2026 | Mar 31, 2026 | 0.16 | 0.22 | +0.06 | +37.50% |
| Feb 24, 2026 | Dec 31, 2025 | 0.24 | 0.29 | +0.05 | +20.83% |
| Nov 5, 2025 | Sep 30, 2025 | 0.12 | 0.22 | +0.10 | +83.33% |
| Aug 5, 2025 | Jun 30, 2025 | 0.18 | 0.17 | -0.01 | -5.56% |
| May 6, 2025 | Mar 31, 2025 | 0.19 | 0.26 | +0.07 | +36.84% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 7, 2024 | JMP Securities | reit | — | Market Perform |
| Jul 25, 2023 | Keybanc | down | Overweight | Sector Weight |
| Jun 21, 2023 | Stifel | reit | Hold | Hold |
| May 22, 2023 | CL King | init | — | Buy |
| May 4, 2023 | Morgan Stanley | main | — | Underweight |
| Feb 22, 2023 | Morgan Stanley | main | — | Underweight |
About Avanos Medical, Inc.
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- Employees
- 2,287
- Website
- avanos.com
News
- Avanos Medical (NYSE:AVNS) and Sintx Technologies (NASDAQ:SINT) Financial Analysis
- Bank of America Corp DE Buys 25,767 Shares of Avanos Medical, Inc. $AVNS
- BlackRock Inc. Buys Shares of 7,468,794 Avanos Medical, Inc. $AVNS
- Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition
- Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners
- Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
- V2X To Replace Avanos Medical In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Monday, July 27
- Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
- Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders?
- Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
Your note
Sign in to keep a note on AVNS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BLACKFORD GARY D | Director | Purchase | Aug 12, 2025 | 0 |
| DELGADO SIGFRIDO | Officer | Stock Award(Grant) | Mar 12, 2026 | 60,005 |
| GALOVAN SCOTT MICHAEL | Chief Financial Officer | Stock Award(Grant) | Mar 12, 2026 | 139,824 |
| GREINER MICHAEL C | Chief Executive Officer | Stock Award(Grant) | Mar 6, 2025 | 224,264 |
| HOLBROOK KERR | Officer | Sale | Nov 17, 2025 | 83,860 |
| JAMES MOJIRADE | General Counsel | Stock Award(Grant) | Apr 21, 2025 | 104,518 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 14.61% | 6,843,733 | 171.02M | Mar 30, 2026 |
| T. Rowe Price Investment Management, Inc. | 11.38% | 5,330,776 | 133.22M | Mar 30, 2026 |
| Brown Advisory Inc. | 4.76% | 2,231,198 | 55.76M | Mar 30, 2026 |
| Dimensional Fund Advisors LP | 4.38% | 2,052,356 | 51.29M | Mar 30, 2026 |
| Armistice Capital, LLC | 4.27% | 2,000,000 | 49.98M | Mar 30, 2026 |
| Vanguard Capital Management LLC | 4.21% | 1,971,965 | 49.28M | Mar 30, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| T. Rowe Price Small-Cap Value Fund, Inc. | 6.06% | 2,839,254 | 70.95M | Mar 30, 2026 |
| iShares Trust-iShares Core S&P Small-Cap ETF | 6.00% | 2,813,195 | 70.30M | May 30, 2026 |
| -Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 3.94% | 1,848,139 | 46.18M | Mar 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 1,410,627 | 35.25M | Mar 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.56% | 1,198,695 | 29.96M | Jun 29, 2026 |
| Thrivent ETF Trust-Thrivent Small-Mid Cap Equity ETF | 2.03% | 951,470 | 23.78M | Mar 30, 2026 |